Beukelman mug 04 2014 1 crop

Associate Professor, Division of Pediatric Rheumatology
Department of Pediatrics

Secondary Appointment: Division of Clinical Immunology & Rheumatology



Children's Park Place North, Suite G10
1601 4th Avenue South
Birmingham, AL 35233-1711





BS, University of Illinois, Urbana-Champaign, IL, 1997
MD, Washington University, Saint Louis, MO, 2001
Intern (Pediatrics): Cincinnati Children’s Hospital Medical Center, OH, 2002
Resident (Pediatrics): Cincinnati Children’s Hospital Medical Center, OH, 2004
Fellow (Pediatric Rheumatology):The Children’s Hospital of Philadelphia, PA, 2007
M.S.C.E., University of Pennsylvania, Philadelphia, PA, 2008


Awards and Honors

2013 ACR/EULAR International Academic Rheumatology Exchange, Early Career Investigator Delegate

2013 Member, American Pediatric Society


Research Description

Dr. Beukelman’s research is focused on determining the safest and most effective treatments for juvenile idiopathic arthritis (JIA), the most common condition in pediatric rheumatology. He has authored or co-authored more than 60 peer-reviewed publications of original research, as well as several textbook chapters. Dr Beukelman was the lead investigator of the first American College of Rheumatology Recommendations for the Treatment of JIA. Dr Beukelman is the Scientific Director of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry, which was established to prospectively evaluate outcomes in the pediatric rheumatic diseases, including the safety and effectiveness of therapeutic agents. He has led several studies using administrative claims data to evaluate the associations between JIA and its treatment and the adverse events of serious infection and cancer.



Click here for a complete list of publications in PubMed. A few selected papers are below

Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG, Patkar NM, Saag KG, Winthrop KL, Curtis JR. 2012. Rates of hospitalized bacterial infection in juvenile idiopathic arthritis and its treatment. Arthritis Rheum  64:2773-80. PMCID: 3409300

Beukelman T, Haynes K, Curtis JR, Xie F, Chen L, Bemrich-Stolz CJ, Delzell E, Saag KG, Solomon DH, Lewis JD. 2012. Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum  64:1263-7. PMCID: PMC3315602

Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Martini A, Rabinovich CE, Ruperto N. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res  63:465-82. PMCID: PMC3222233



SOM Epilogue Menu